News Focus
News Focus
Followers 58
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

Re: georgejjl post# 256505

Saturday, 06/27/2020 10:06:31 AM

Saturday, June 27, 2020 10:06:31 AM

Post# of 515611
These present some of the metrics for Quality of Life (QOL), we see them as having limitless human value, PRICELESS. So, in case anyone wants to understand if all of this PDD is trial justified, show them this. Splain, this is only the beginning.

georgeiil

Top-line results from the Anavex PDD trial should be very easy and quick to analyze using computerized statistical analysis programs that are commercially available.

Below is the list of endpoints for the trial to determine the top-line results:

Quote:

Outcome Measures:


Primary Outcome Measures:
Cognitive Drug Research (CDR) Computerized Assessment System Continuity of Attention [ Time Frame: 14 weeks ]
Change from Baseline to End of Treatment in Continuity of Attention as measured by Cognitive Drug Research (CDR) Computerized Assessment System Continuity of Attention test

Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 [ Time Frame: 14 weeks ]
Assess the safety and tolerability of ANAVEX2-73 compared to placebo


Secondary Outcome Measures:
MDS-UPDRS Part III Total Score (Motor Scores) [ Time Frame: 14 weeks ]
Change from baseline to End of Treatment as measured by MDS-UPDRS Part III Total Score (Motor Scores)

SDS-CL-25 [ Time Frame: 14 weeks ]
Incidence of sleep disorders symptoms (SDS-CL-25)



https://clinicaltrials.gov/ct2/show/NCT03774459

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News